1. World Health Organization. Anti-tuberculosis drug resistance in the world: the WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance 1994-1997 (WHO/TB/97.229). World Health Organization, Geneva, 1997.
2. Crofton J. The contribution of treatment to the prevention of tuberculosis. Bull Int Union Against Tuber 1962; 32: 643–653.
3. Iseman MD. Tailoring a time bomb: inadvertent genetic engineering. Am Rev Respir Dis 1985; 132: 735–736.
4. Farmer PE, Bayona J, Becerra M, et al. The dilemma of MDRTB in the global era. Int J Tuberc Lung Dis 1998; 2: 869–876.
5. Manalo F, Tan F, Sbarbaro JA, Iseman MD. Community-based short-course treatment of pulmonary tuberculosis in a developing nation. Initial report of an eight-month, largely intermittent regimen in a population with a high prevalence of drug resistance. Am Rev Respir Dis 1990; 142: 1301–1305.